Search bioRxiv⌕ Search

Biology subjects

Grazian, C.

Publications and source records attributed to Grazian, C..

2 recordsLinked to original sources

SPSID: A single-parameter shrinkage inverse-diffusion for denoising gene regulatory networks

Inferring gene regulatory networks (GRNs) from expression data is a fundamental problem in systems biology, but its accuracy is often undermined by structural noise arising from transitive correlations. These indirect interactions can obscure the true regulatory architecture, leading to a high rate of false positives. To address this, we introduce SPSID (Single-Parameter Shrinkage Inverse-Diffusion), a novel and robust network denoising framework. SPSID employs a principled spectral filter, built upon a shrinkage-regularized inverse-diffusion operator, to mathematically distinguish direct, one-step interactions from multi-step, indirect paths. This approach guarantees numerical stability and, through a fixed default parameter, effectively eliminates the need for data-dependent tuning. We conducted a comprehensive evaluation of SPSID on both extensive simulations and the gold-standard DREAM5 benchmark. The results demonstrate that SPSID outperforms state-of-the-art baseline methods in both AUROC and AUPR, exhibiting good stability across diverse network conditions. Furthermore, it functions as a post-processing tool, elevating the performance of multiple upstream GRN inference methods. By providing a computationally efficient and parameter-free solution to filter structural noise, SPSID offers a readily applicable tool for uncovering the underlying topology of complex biological networks with greater fidelity.

bioinformatics↗

Validation of a 14-drug microtitre plate that includes delamanid and bedaquiline for susceptibility testing of M. tuberculosis

UKMYC5 is a 96-well microtitre plate designed by the Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC) to enable the measurement of minimum inhibitory concentrations (MICs) of 14 different anti-TB compounds for >30,000 clinical tuberculosis isolates. Unlike the MYCOTB plate, on which UKMYC5 is based, the plate included two new (bedaquiline and delamanid) and two repurposed (clofazimine and linezolid) compounds. UKMYC5 plates were tested by seven laboratories on four continents using a panel of 19 external quality assessment (EQA) strains, including H37Rv. To assess the optimal combination of reading method and incubation time, MICs were measured from each plate by two readers using three methods (mirrored-box, microscope and Vizion Digital viewing system) after 7, 10, 14 and 21 days incubation. In addition, all EQA strains were whole-genome sequenced and phenotypically characterized by 7H10/7H11 agar proportion method (APM) and MGIT960. We conclude that the UKMYC5 plate is optimally read using the Vizion system after 14 days incubation, achieving an inter-reader agreement of 97.9% and intra- and inter-laboratory reproducibilities of 95.6% and 93.1%, respectively. The mirrored-box had similar reproducibilities. Strains classified as resistant by APM, MGIT960 or the presence of mutations known to confer resistance consistently record elevated MICs compared with those strains classified as susceptible. Finally, the UKMYC5 plate records intermediate MICs for one strain which the APM measured MICs close the applied critical concentration, providing early evidence that the UKMYC5 plate can quantitatively measure the magnitude of resistance to anti-TB compounds due to specific genetic variation.

microbiology↗